Trial intelligence / Profile preview

Hepatic Hilum Nerve Block for Pain Control During Liver Interventions

NCT04769713Phase 4Unknown

Sponsor
McGill University Health Centre
Start
Nov 2021
Primary completion
Jun 2023
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of ropivacaine in procedural pain, sponsored by McGill University Health Centre. Status: unknown.

02

Drugs

ropivacaine
03

Conditions

procedural pain

Beyond the preview

Go deeper on NCT04769713.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04769713.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call